Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Colinz Laboratories Ltd (NSE: COLINZ), ISIN INE923C01011 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
COLINZ last traded at ₹73.90 (-1.28%), with a 52-week range of ₹36.11 to ₹87.91 (as of 23 Sep 2026).
Shareholding as of Dec 2025: promoters 66.00%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 28/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.